MI
BME icon

Motiv8 Investments’s BlackRock Health Sciences Trust BME Stock Holding History

Motiv8 Investments’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1 Buy
+22
New +$869 ﹤0.01% 821

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Motiv8 Investments's BME Position: Q4 2025 in Review

Motiv8 Investments opened a new position in BlackRock Health Sciences Trust (BME) in Q4 2025: 22 shares worth $1. The stake represents ﹤0.01% of the portfolio and ranks #821 among its holdings.

77 funds tracked by Wall St. Rank hold BME as of Q4 2025.

  • Motiv8 Investments held 22 shares of BlackRock Health Sciences Trust worth $1 as of Q4 2025.
  • BlackRock Health Sciences Trust was a new Motiv8 Investments position in Q4 2025.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #821 holding.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.